Latest market price
150.90
+4.57+3.12%
OverviewShort InterestFilings
PVLAQT82Palvella Therapeutics, Inc.·NASDAQ
150.90+3.12%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 28, 20268-KCurrent report
Oct 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 23, 20264Statement of changes in beneficial ownership
Oct 14, 20264Statement of changes in beneficial ownership
Sep 18, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 04, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 10, 2026SC 13GBeneficial ownership statement (passive)
Aug 04, 20268-KCurrent report
Aug 04, 2026S-8Registration of employee benefit securities
Aug 04, 202610-QQuarterly report
Aug 03, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20264Statement of changes in beneficial ownership
Jul 14, 20268-KCurrent report
Jul 01, 20263Initial statement of beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 30, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 16, 20268-KCurrent report
Jun 16, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
#1 / 25 of 326
Page
▼
/ 14